Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
16.17
+1.68 (11.59%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cadrenal Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 29 | 10 | - |
| Enterprise Value | 24 | 1 | - |
| Last Close Price | 16.17 | 11.10 | - |
| PB Ratio | 5.85 | 1.25 | - |
| P/TBV Ratio | 4.27 | 1.25 | - |
| Debt / Equity Ratio | 0.00 | 0.00 | -0.12 |
| Quick Ratio | 3.44 | 10.16 | 0.02 |
| Current Ratio | 3.69 | 10.27 | 0.55 |
| Return on Equity (ROE) | -125.15% | -780.59% | - |
| Return on Assets (ROA) | -70.99% | -102.62% | - |
| Return on Capital (ROIC) | -81.50% | -340.35% | - |
| Earnings Yield | -26.40% | -86.73% | - |
| FCF Yield | -21.72% | -36.67% | - |
| Buyback Yield / Dilution | -40.03% | -70.99% | - |
| Total Shareholder Return | -40.03% | -70.99% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.